Domain Therapeutics announces first patient dosed with

Domain Therapeutics announces first patient dosed with DT-9081 in phase I clinical study in patients with advanced, recurrent or metastatic solid tumors:...

Related Keywords

United States ,Paris ,France General ,France ,Saint Luc ,Haute Normandie ,Belgium ,Montreal ,Quebec ,Canada ,Brussels ,Bruxelles Capitale ,America ,Pascal Neuville ,Amber Fennell ,Namrata Taak ,Jean Pierre Delord ,Institut Jules Bordet ,Jean Pascal Machiels ,Annie Florence Loyer ,Institut Claudius Regaud ,Nuria Kotecki ,Christophe Le Tourneau ,Maya Bennison ,Institut Curie ,Merck Kga ,Merck Kgaa ,Consilium Strategic Communications ,Domain Therapeutics ,Saint Luc Hospital Brussels ,Lead Investigator ,Prof Jean Pascal Machiels ,Saint Luc Hospital ,Prof Christophe Le Tourneau ,Prof Jean Pierre Delord ,